Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine

J Infect Dis. 2016 Dec 15;214(12):1796-1799. doi: 10.1093/infdis/jiw341. Epub 2016 Aug 5.

Authors

Annelies Wilder-Smith^{1

2}, Kirsten S Vannice³, Joachim Hombach³, Jeremy Farrar^{4

5}, Terry Nolan^{4

6}

Affiliations

¹ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
² Institute of Public Health, University of Heidelberg, Germany.
³ Secretariat.
⁴ Strategic Advisory Group of Experts Working Group on Dengue Vaccines, World Health Organization, Geneva, Switzerland.
⁵ Wellcome Trust, London, United Kingdom.
⁶ School of Population and Global Health, University of Melbourne, Australia.

PMID: 27496977
DOI: 10.1093/infdis/jiw341

No abstract available

Keywords: CYD-TDV vaccine; SAGE; World Health Organization; dengue; evidence-based guidelines; public health impact.

Publication types

Comment

MeSH terms

Antibodies, Viral
Dengue Vaccines*
Dengue*
Humans
Vaccines, Attenuated
World Health Organization

Substances

Antibodies, Viral
Dengue Vaccines
Vaccines, Attenuated